Boston Scientific's surprise bid for Guidant triggered rumors on Wall Street of further consolidation in the medical device market. Shares of St. Jude Medical rose about 5 percent on speculation that the company could be the object of a takeover bid by another company. Most analysts are ruling out market leader Medtronic as a target, arguing that the company would be too expensive. "This is one of the hottest areas of medical technology and will be for several years," comments Phillip Nalbone of RBC Capital Markets. "It has big numbers, high growth and very attractive margins."
- see this article from MarketWatch
ALSO: If Guidant decides to go with Boston Scientific's offer, the deal will create a powerhouse. Article